Home > Specialties > Reagents, Molecular Assay, Infection, Virus, Varicella-Zoster

Reagents, Molecular Assay, Infection, Virus, Varicella-Zoster

Definition : Molecular assay reagents intended to identify varicella-zoster virus, a DNA virus of the genus Varicellavirus, family Herpesviridae, by detecting the nucleic acid of the target virus. Varicella-zoster viruses cause chickenpox (varicella), an infectious disease typically transmitted by direct contact or through the respiratory route and characterized by the appearance of vesicular lesions on the skin and mucous membranes. Activation of varicella-zoster virus from a previous chickenpox (varicella) infection may cause herpes zoster (also called shingles), a self-limited infection that affects ganglia and their areas of innervation, producing severe neuralgic pain and vesicles on the skin.

Entry Terms : "Zoster Detection/Identification Reagents" , "Zoster (Varicella-Zoster) Virus Reagents, Identification" , "VZV (Varicella-Zoster Virus) Detection/Identification Reagents" , "Varicella-Zoster Virus (VZV) Detection/Identification Reagents" , "Varicella-Zoster Reagents, Identification" , "Varicella-Zoster Detection/Identification Reagents" , "Varicella (Chickenpox) Virus Reagents, Identification" , "Herpes Zoster Virus Detection/Identification Reagents" , "Chickenpox Virus Determination Reagents" , "Chickenpox (Varicella-Zoster) Virus Reagents, Identification" , "B568 Shingles Virus Detection/Identification Reagents"

UMDC code : 19250

   

1-17 of 17 Match(es).

Applied Biosystems

Our newly expanded portfolio of market-leading lab services can provide your high-performance lab with a comprehensive suite of services, or just the ones you want. From business consulting and protocol development, to instrument repair and optimization, our services can help you increase your lab's productivity and efficiency.

Focus Diagnostics Inc

As part of the Quest Diagnostics family, Focus Diagnostics, Inc. is committed to providing proven and reliable products its customers have grown accustomed to throughout the years. Since its founding in 1978, Focus Diagnostics has grown its business from specialized laboratory testing to manufacturing its high-quality laboratory tests for hospitals and commercial laboratories worldwide. These manufactured tests are built in response to diagnostic testing trends identified and evaluated by Focus Diagnostics and used in Quest Diagnostics' national laboratories.

Gen-Probe Inc

Gen-Probe is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility.

Gen-Probe Life Sciences Ltd

Gen-Probe Life Sciences Ltd

HyTest Ltd

HyTest Ltd

Innogenetics Inc

Innogenetics NV is an international diagnostic company that develops and markets diagnostic products to improve therapy management and patient health.

QIAGEN AG

QIAGEN AG

QIAGEN GmbH

QIAGEN GmbH

QIAGEN Inc

QIAGEN is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

QIAGEN Inc (Canada)

QIAGEN Inc (Canada)

QIAGEN KK

QIAGEN KK

QIAGEN Ltd

QIAGEN Ltd

QIAGEN Pty Ltd

QIAGEN Pty Ltd

QIAGEN SA

QIAGEN SA

QIAGEN SpA

QIAGEN SpA

Roche Molecular Systems Inc

Roche Molecular Diagnostics (RMD) is a business area of Roche Diagnostics (Basel, Switzerland) that develops, manufactures and supplies a wide array of innovative medical diagnostic products, services, tests, platforms and technologies. With its broad portfolio of oncology, virology, microbiology and blood screening tests, RMD's clients include researchers, physicians, patients, hospitals, laboratories and blood banks around the world.

Zeus Scientific Inc

ZEUS Scientific is a privately held corporation that was founded in 1976. The company began producing IFA (immunofluorescence assay) test systems followed ELISA and now multiplex (AtheNA Multi-Lyte) immunoassays. New products are developed to expand the menu which allows laboratories to run an increasing number of assays with common protocols and common reagents, as well as developing new tests to more accurately diagnose patients. In 1987 ZEUS Scientific was the first company to develop, receive appropriate regulatory clearance and bring to market a serological assay to test for Lyme disease – a condition with high prevalence in the local community where ZEUS Scientific is located.

1-17 of 17 Match(es).

 

Medical Product Guide Optometric Management Product Guide